A combination of nontoxic dietary and hyperbaric oxygen therapies effectively increased survival time in a mouse model of aggressive metastatic cancer, a research team from the Hyperbaric Biomedical Research Laboratory at the University of South Florida has found. The study, “The Ketogenic Diet and Hyperbaric Oxygen Therapy Prolong Survival in Mice with Systemic Metastatic Cancer,” was published online today in …
Doctors bail out on their practices
Doctors who own private practices are looking for a way out. Fed up with their rising business expenses and shrinking payouts from insurers, many are selling their practices to hospitals. It’s happening nationwide and has picked up pace, said Tony Stajduhar, president at Jackson & Coker, a physician recruitment firm. Experts say the number of physicians unloading their practices to …
Bipartisan Bill to Improve Cancer Care is Introduced in House by Representatives Capps and Boustany
Planning Actively for Cancer Treatment (PACT) Act would enhance care of millions of Medicare patients Washington, D.C. – Congresswoman Lois Capps (D-CA) and Congressman Charles Boustany, Jr., M.D., (R-LA) today introduced the Planning Actively for Cancer Treatment (PACT) Act (H.R. 2477), which would significantly improve the quality and coordination of care for Medicare patients with cancer. The bill is the …
More Bridges, More Options in Cancer Treatment – ASCO 2013 Wrap Up
POSTED IN Blog, Healthcare, Pharma The ASCO 2013 Annual Meeting has come to a close and the over 25,000 attendees have returned home armed with new ideas around the advances in cancer treatment. The conference highlighted immunotherapies, breakthrough drugs and difficult issues facing the oncology community. Immunotherapies were the hottest new topic in oncotherapy development, you expect to hear much …
MD Anderson Researcher Reassesses Avastin’s Function In Treating Brain Cancer
From BioNews TX With the cancer drug Avastin on the ropes after losing FDA support for the treatment of breast cancer two years ago and an increasing chorus of criticism, an MD Anderson researcher has weighed in on where he thinks the drug’s effectiveness lies. In a recent cancer study conducted at MD Anderson for the initial treatment of glioblastoma, one …